Health-related quality of life of patients treated with different fractionation schedules for early prostate cancer compared to the age-standardized general male population

HIGHLIGHTS

• who: Petri Reinikainen from the Patients and Radiation Therapy Planning Men up to , years of age with a biopsy-confirmed localized, c-T2cN , prostate cancer with , or , intermediate risk factors (IFRs) according to NCCN criteria were eligible for this study, IFRs were, b-T2c disease, Gleason score of , or a prostatespecific antigen (PSA) level of , to , ng/mL. Androgen deprivation therapy (ADT) or need of transurethral resection of the prostate (TURP) were exclusion criteria. Between May , and December, a total of , patients (approximately, %-95% of eligible patients) were recruited from Tampere University Hospital. The first , patients were . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.